CML stem cells are known to reside in the lin(−) CD34+CD38− population and recently it was reported that the progenitor cells acquire stem cell properties which results in the progression of the disease3. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.